Healthstream (HSTM) Cash & Equivalents (2010 - 2026)

Healthstream (HSTM) has 17 years of Cash & Equivalents data on file, last reported at $48.7 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 36.98% year-over-year to $48.7 million in Q1 2026; TTM through Mar 2026 was $48.7 million, a 36.98% decrease from a year earlier, with the FY2025 full-year figure at $36.2 million, down 39.19% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $48.7 million, up from $36.2 million in the prior quarter.
• Over the last five years, Cash & Equivalents for HSTM reached as high as $77.3 million in Q1 2025 and fell as low as $25.8 million in Q2 2023.
• Historically, Cash & Equivalents has averaged $48.1 million across 5 years, with a median of $48.3 million in 2022.
• Across the five-year window, Cash & Equivalents soared 78.77% in 2024 and tumbled 39.19% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $46.0 million in 2022, then decreased by 12.36% to $40.3 million in 2023, then surged by 47.45% to $59.5 million in 2024, then tumbled by 39.19% to $36.2 million in 2025, then soared by 34.71% to $48.7 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $48.7 million in Q1 2026, $36.2 million in Q4 2025, and $53.5 million in Q3 2025.